By
Latest Stories
Don’t miss our hot and upcoming stories
What Does the Tempus–Verastem CDx Collaboration Mean for the Future of AI-Driven Precision Oncology and FDA Approvals?
Key Highlights: FDA milestone: a new era for targeted LGSOC therapiesTempus AI and Verastem Oncology…
Is the Devano and Verge Genomics AI Collaboration the Next Big Leap in Biomedical Data Curation and Drug Discovery?
Key Executive Takeaways Transforming Drug Discovery Through AI-Driven Data IntegrationVerge Genomics, a clinical-stage biotech innovator,…
Can Verge Genomics’ AI-Powered VRG50635 Trial Redefine ALS Drug Development With Digital Biomarker Breakthroughs?
Key Executive Takeaways Digital Biomarkers Show Disease Progression—Before Drug InterventionVerge Genomics has demonstrated that digital…
Why Is insitro’s $25M Milestone with BMS a Game-Changer for AI-Powered ALS Target Selection?
$25 Million Milestone Reached in Collaboration with Bristol Myers Squibb Unlocks First Novel ALS Target…